Publication | Closed Access

Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion

Potent Tumor CytolysisDrug TargetingEffector Cell RecruitmentImmunologyImmune Checkpoint InhibitorTumor TargetingVivo B-cell DepletionImmunotherapyMedicineCell BiologyCancer ResearchNovel TherapyTumor Biology